+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain Drug"

From
Neuropathic Pain Drug Market in the United States - Product Thumbnail Image

Neuropathic Pain Drug Market in the United States

  • Report
  • March 2026
  • 210 Pages
  • United States
From
Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • August 2026
  • 386 Pages
  • Global
From
Neuropathic Pain Market Report 2026 - Product Thumbnail Image

Neuropathic Pain Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetic Neuropathic Pain - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Chronic Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Chronic Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
From
From
Neuropathy Pain Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuropathy Pain Treatment Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 183 Pages
  • Global
From
Pregabalin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pregabalin Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 185 Pages
  • Global
From
Neuralgia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuralgia Treatment Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 196 Pages
  • Global
From
From
Diabetic Neuropathy Market Report 2026 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Paresthesia Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment Market - Global Strategic Business Report

  • Report
  • August 2026
  • 381 Pages
  • Global
From
Pregabalin Market - Global Strategic Business Report - Product Thumbnail Image

Pregabalin Market - Global Strategic Business Report

  • Report
  • August 2026
  • 372 Pages
  • Global
From
From
Loading Indicator

The Neuropathic Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathic pain drugs are used to treat chronic pain caused by nerve damage, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. These drugs are typically divided into two categories: anticonvulsants and antidepressants. Anticonvulsants are used to reduce the intensity of nerve pain, while antidepressants are used to reduce the frequency of nerve pain. Commonly prescribed neuropathic pain drugs include pregabalin, gabapentin, duloxetine, and amitriptyline. Some companies in the Neuropathic Pain Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis. Show Less Read more